THRIVE 2.0 Program for Preventing Childhood Obesity
(THRIVE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program designed to prevent obesity in infants by teaching caregivers healthy parenting practices. The focus is on families of color or those who are economically marginalized, with sessions delivered during regular pediatric visits. Researchers aim to determine if this approach helps infants grow at a healthy rate without rapid weight gain. Suitable candidates include caregivers of newborns from racially diverse or low-income backgrounds who receive care at the trial's pediatric center. As a Phase 2 trial, this research measures the program's effectiveness in an initial, smaller group, allowing participants to contribute to important early findings.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that the THRIVE 2.0 program is safe for infants and caregivers?
Research shows that the THRIVE 2.0 program aims to prevent rapid weight gain in infants by teaching parents healthy habits related to eating, sleeping, and self-control. Studies on similar programs have found that participants generally respond well to them.
The THRIVE 2.0 program includes four sessions for parents and infants, integrated into regular pediatric checkups, making participation convenient and easy for families. Past research has not reported any serious side effects from the program.
Since this trial is in an early stage, initial results appear promising, but more research is needed to confirm the program's long-term safety and effectiveness. Including it in standard pediatric visits emphasizes safety and ease for families.12345Why are researchers excited about this trial?
Researchers are excited about the THRIVE 2.0 program because it takes a proactive approach to preventing childhood obesity by focusing on teaching parents responsive parenting techniques. Unlike traditional methods that may address obesity after it develops, THRIVE 2.0 integrates lesson plans during routine well-child visits to establish healthy eating, sleeping, and regulation habits right from infancy. This method empowers parents to create a nurturing environment that supports vital growth and healthy development, potentially preventing the onset of obesity before it starts. By addressing these habits early, researchers hope to see long-term benefits in children’s growth and health.
What evidence suggests that the THRIVE 2.0 program is effective for preventing childhood obesity?
Research has shown that the THRIVE 2.0 program, which participants in this trial may receive, helps prevent rapid weight gain in babies. This program teaches parents to respond to their baby's needs in ways that encourage healthy eating, sleeping, and self-control from an early age. Early results suggest these methods can lower the risk of obesity as children grow. Including this program in regular doctor visits integrates it naturally into a child's early health care. Overall, evidence supports that the THRIVE 2.0 program effectively promotes steady weight gain and healthy development in infants.12345
Who Is on the Research Team?
Tiffany Rybak, PhD
Principal Investigator
Children's Hospital Medical Center, Cincinnati
Are You a Good Fit for This Trial?
This trial is for infants of color or from low-income families, born weighing at least 2500 grams and delivered between 37-42 weeks. They must be receiving care in the study's pediatric primary care setting and have English-speaking caregivers. Infants with certain health conditions, drug exposures, or whose families plan to move away within a year are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the THRIVE 2.0 responsive parenting intervention during well-child visits at 1, 2, 4, and 6 months
Post-treatment Assessment
Assessment of primary and secondary outcomes, including conditional weight gain and various questionnaires
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 12 months
What Are the Treatments Tested in This Trial?
Interventions
- THRIVE 2.0
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Hospital Medical Center, Cincinnati
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator